Spanish Red Biotech Pipeline

Gilead Sciences

Brexucabtagene autoleucel 

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Basket (rare B-cell malignancies)
Phase: 2Phase II in Spain, 1Phase I in Spain